IL-6, along with C-reactive protein (CRP), is commonly used as a serum biomarker to monitor inflammation in patients with cancer, infection, or autoimmune diseases due to its crucial role in activating and sustaining the inflammatory response [46]. This evidence concerns the gene CRP and infection.